Prevalence of Obesity Increasing in Cancer Survivors

Share this content:
The estimated rate of annual increase in obesity prevalence among patients with a history of cancer has increased.
The estimated rate of annual increase in obesity prevalence among patients with a history of cancer has increased.

(HealthDay News) — From 1997 to 2014 the estimated rate of annual increase in obesity prevalence was higher for adults with a history of cancer, according to a study published online July 25 in the Journal of Clinical Oncology.

Heather Greenlee, PhD, from Columbia University in New York City, and colleagues examined trends in obesity prevalence among cancer survivors by using a population-based nationally representative sample of 538 969 noninstitutionalized US adults. A total of 32 447 cancer survivors were identified, with breast, prostate, and colorectal cancer the most common diagnoses.

The researchers observed increases in the prevalence of obesity from 1997 to 2014, from 22.4% to 31.7% in cancer survivors and from 20.9% to 29.5% in adults without a history of cancer. The estimated rate of annual increase in obesity prevalence was higher for adults with a history of cancer than in those without a history of cancer. 

The estimated rate of annual increase in prevalence of obesity was 3.1% and 3.7%, respectively, for female and male colorectal cancer survivors; 3% for breast cancer survivors; and 2.1% for prostate cancer survivors. Colorectal cancer survivors, breast cancer survivors, and non-Hispanic blacks had the highest rates of increasing obesity burden.

"From 1997 to 2014, obesity increased more rapidly among adult cancer survivors compared with the general population," the researchers wrote.

Disclosures: Two authors disclosed financial ties to EHE International.

Reference

  1. Greenlee H, Shi Z, Sardo Molmenti Rundle A, Tsai WY. Trends in Obesity Prevalence in Adults With a History of Cancer: Results From the US National Health Interview Survey, 1997 to 2014. J Clin Oncol. 2016. doi:10.1200/JCO.2016.66.4391.
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters



CME Focus